Sirona Biochem Corp. (CVE:SBM – Get Free Report) shares were down 16.7% on Wednesday . The company traded as low as C$0.05 and last traded at C$0.05. Approximately 113,000 shares were traded during mid-day trading, an increase of 91% from the average daily volume of 59,069 shares. The stock had previously closed at C$0.06.
Sirona Biochem Price Performance
The business’s 50 day moving average is C$0.06 and its two-hundred day moving average is C$0.06. The firm has a market capitalization of C$12.84 million, a PE ratio of -5.00 and a beta of -0.03. The company has a debt-to-equity ratio of 219.21, a current ratio of 0.34 and a quick ratio of 2.41.
About Sirona Biochem
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Featured Stories
- Five stocks we like better than Sirona Biochem
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Why Invest in High-Yield Dividend Stocks?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is the Dow Jones Industrial Average (DJIA)?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
